Tumor purity is an important factor affecting the analysis of immune infiltration in clinical cancer tissues, so after correction for tumor purity, different types of immune cells in invasive breast cancer were evaluated, and the expression of COL11A1 was significantly correlated with most immune markers (Supplementary Table S1). The gene discussed is COL11A1; the disease is cancer.